Alt Data for COVID-19: Tracking the Vaccine Rollout

Keava Low, Research Analyst (London)

Neudata Intelligence
Post feature

The development and rollout of a safe and effective vaccine is viewed by many as the light at the end of the tunnel for the COVID-19 pandemic and a catalyst for the global economic recovery. As a number of COVID-19 vaccines receive regulatory approval, all eyes are on the processes and infrastructure required for vaccine production, procurement, distribution, and administration.

WHY TRACK THIS?